Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in HIV and AIDS|July 16, 2021
Immunological effector mechanisms in HIV-1 elite controllersCiputra Adijaya Hartana, Xu G Yu
Cell Reports|December 4, 2023
IL-15-dependent immune crosstalk between natural killer cells and dendritic cells in HIV-1 elite controllersCiputra Adijaya Hartana, Melanie Lancien, Ce Gao, et al.
British Journal of Cancer|September 7, 2016
Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumoursCiputra Adijaya Hartana, Johan Kinn, Robert Rosenblatt, et al.
The Journal of Clinical Investigation|May 3, 2021
Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllersCiputra Adijaya Hartana, Yelizaveta Rassadkina, Ce Gao, et al.
Expert Opinion on Biological Therapy|April 16, 2019
Facing the future: challenges and opportunities in adoptive T cell therapy in cancerIsabelle Magalhaes, Claudia Carvalho-Queiroz, Ciputra Adijaya Hartana, et al.
Plos One|July 3, 2018
Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathwayCiputra Adijaya Hartana, Emma Ahlén Bergman, A Ali Zirakzadeh, et al.
European Urology|July 21, 2018
Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder CancerDavid Krantz, Ciputra Adijaya Hartana, Malin E Winerdal, et al.
Nature|January 4, 2023
Phenotypic signatures of immune selection in HIV-1 reservoir cellsWeiwei Sun, Ce Gao, Ciputra Adijaya Hartana, et al.
The Journal of Infectious Diseases|May 18, 2023
Immune Modulation of HIV-1 Reservoir Size in Early-Treated NeonatesCiputra Adijaya Hartana, Pilar Garcia Broncano, Kenneth Maswabi, et al.
Clinical Immunology (Orlando, Fla.)|December 28, 2016
Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancerA Ali Zirakzadeh, Johan Kinn, David Krantz, et al.
Pageof 2